| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 410.48M | 392.25M | 374.28M | 344.85M | 337.34M |
| Gross Profit | 106.74M | 102.52M | 107.80M | 110.32M | 114.42M |
| EBITDA | 4.96M | -55.53M | -22.00M | 8.11M | 41.80M |
| Net Income | -32.84M | -45.38M | -43.98M | -18.23M | 18.59M |
Balance Sheet | |||||
| Total Assets | 1.04B | 1.02B | 1.08B | 906.96M | 866.43M |
| Cash, Cash Equivalents and Short-Term Investments | 194.87M | 133.86M | 235.99M | 99.45M | 79.49M |
| Total Debt | 322.24M | 211.73M | 160.40M | 164.58M | 163.78M |
| Total Liabilities | 500.89M | 451.69M | 460.21M | 404.36M | 343.51M |
| Stockholders Equity | 529.40M | 560.27M | 609.41M | 491.05M | 510.99M |
Cash Flow | |||||
| Free Cash Flow | -40.54M | -142.24M | 794.00K | 4.08M | 10.24M |
| Operating Cash Flow | -9.49M | -127.93M | 7.61M | 16.06M | 11.70M |
| Investing Cash Flow | -29.09M | -617.00K | -26.07M | 41.74M | -5.18M |
| Financing Cash Flow | 42.53M | 42.64M | 153.52M | -9.08M | -15.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | HK$2.83B | 3.28 | 18.00% | 5.75% | 3.21% | -0.86% | |
68 Neutral | HK$26.89B | 6.29 | 17.75% | 2.24% | 15.73% | 49.88% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | HK$600.00M | -2.93 | -9.29% | 7.47% | -23.05% | -511.63% | |
51 Neutral | HK$455.61M | -1.78 | -16.83% | ― | -15.04% | 71.02% | |
47 Neutral | HK$544.91M | -2.33 | -22.56% | ― | 30.28% | 34.98% | |
43 Neutral | HK$190.98M | -18.54 | -6.19% | ― | 5.07% | 28.18% |